Estate Counselors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Estate Counselors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-64,400	Closed	-$3.3M	–	74
2015 Q4	$3.3M	Hold	64,400	–	–	1.35%	22
2015 Q3	$2.99M	Sell	64,400 -30,000	-32%	-$1.81M	1.2%	22
2015 Q2	$5.88M	Hold	94,400	–	–	2.04%	19
2015 Q1	$5.83M	Hold	94,400	–	–	2.07%	19
2014 Q4	$5.1M	Hold	94,400	–	–	1.8%	20
2014 Q3	$5M	Hold	94,400	–	–	1.93%	20
2014 Q2	$4.9M	Hold	94,400	–	–	1.87%	21
2014 Q1	$4.42M	Sell	94,400 -142,200	-60%	-$6.72M	1.77%	22
2013 Q4	$10.4M	Hold	236,600	–	–	4.62%	9
2013 Q3	$9.11M	Hold	236,600	–	–	4.21%	9
2013 Q2	$8.35M	Buy	+236,600	New	+$7.99M	4.23%	9

Other funds holding XPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

KHLMVGHM

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $1.53B AUM 20.88% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Estate Counselors's XPH Position: Q1 2016 in Review

Estate Counselors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2016, closing a stake of 64,400 shares — an estimated $3.3M sold.

Estate Counselors first reported a position in XPH in Q2 2013 and held it in 11 quarters. The position peaked at $10.4M in Q4 2013. 71 funds tracked by Wall St. Rank hold XPH as of Q1 2016.

Estate Counselors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
Estate Counselors sold 64,400 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2016, an estimated $3.3M.
Estate Counselors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 11 quarters.
Estate Counselors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $10.4M in Q4 2013.
71 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2016.

Based on Estate Counselors's 13F filing for Q1 2016, filed 9 May 2016.